Hypopressive-Core Stabilization With and Without Whole-Body Vibration in Postpartum Pelvic Girdle Pain
NCT07920406, Not applicable, Active not recruiting, University of Management and Technology Lahore
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Hypopressive-Core Stabilization With and Without Whole-Body Vibration in Postpartum Pelvic Girdle Pain | ClinicalTrials.gov |
| NCT number | NCT07920406 | ClinicalTrials.gov |
| Status | Active not recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 30 participants, actual | ClinicalTrials.gov |
| Lead sponsor | University of Management and Technology Lahore | ClinicalTrials.gov |
| Conditions | Postpartum Pelvic Girdle Pain | ClinicalTrials.gov |
| Interventions | Hypopressive-core stabilization exercises combined with whole-body vibration, hypopressive and core stabilization | ClinicalTrials.gov |
| First posted | 2026-11-05 | ClinicalTrials.gov |
| Last updated | 2026-11-05 | ClinicalTrials.gov |
Registered outcomes 3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Numeric Pain Rating Scale (NPRS) | baseline after 8 week | A simple 11-point scale where participants rate their current pain from 0 to 10. 0 means no pain; 1-3 is mild pain (nagging, annoying, interfering little with daily activities); 4-6 is moderate pain (interferes significantly with daily activities); and 7-10 is severe pain (disabling, unable to perform daily activities | ClinicalTrials.gov |
| Primary | Pelvic Girdle Questionnaire (PGQ) | baseline after 8 week | The first condition-specific questionnaire for women with pregnancy-related pelvic girdle pain. It has 25 items scored from 0 to 3: 20 on activity limitations and 5 on symptoms, for a maximum of 75. The total is converted to a percentage, where 0% means no disability and 100% means severe disability. It has high reliability (ICC 0.93 for activity, 0.91 for symptoms) and is recommended as a primary outcome measure in this population | ClinicalTrials.gov |
| Primary | Timed Up and Go (TUG) test | baseline after 8 week | The participant stands up from a standard armchair (about 46 cm high) on the command "go," walks 3 metres at a brisk pace, turns, walks back, and sits down. The time is recorded in seconds. The test is a brief measure of functional mobility. Use the same standardized procedure at each assessment and interpret results alongside the participant's symptoms and other outcome measures. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)